Autolus Therapeutics PLC
NASDAQ:AUTL

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
NASDAQ:AUTL
Watchlist
Price: 1.62 USD
Market Cap: 431.1m USD

Wall Street
Price Targets

AUTL Price Targets Summary
Autolus Therapeutics PLC

Wall Street analysts forecast AUTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUTL is 9.49 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

Lowest
Price Target
5.05 USD
212% Upside
Average
Price Target
9.49 USD
486% Upside
Highest
Price Target
13.65 USD
743% Upside
Autolus Therapeutics PLC Competitors:
Price Targets
BNTX
BioNTech SE
52% Upside
NVAX
Novavax Inc
98% Upside
TNG
Transgene SA
72% Upside
AMGN
Amgen Inc
3% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
36% Upside
688331
RemeGen Co Ltd
16% Upside
SVRA
Savara Inc
59% Upside

Revenue
Forecast

Revenue Estimate
Autolus Therapeutics PLC

For the last 7 years the compound annual growth rate for Autolus Therapeutics PLC's revenue is 29%. The projected CAGR for the next 4 years is 156%.

29%
Past Growth
156%
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Autolus Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Autolus Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AUTL's stock price target?
Price Target
9.49 USD

According to Wall Street analysts, the average 1-year price target for AUTL is 9.49 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

What is Autolus Therapeutics PLC's Revenue forecast?
Projected CAGR
156%

For the last 7 years the compound annual growth rate for Autolus Therapeutics PLC's revenue is 29%. The projected CAGR for the next 4 years is 156%.

Back to Top